| 产品详情 |
| Edit |   |
|---|
| Product Name | Ritonavir |
|---|
| Description | Ritonavir is an orally bioavailable HIV-1 and HIV-2 protease inhibitor (EC50 values are 0.022-0.13 and 0.16 µM, respectively). Through CYP3A4 inhibition, low doses of ritonavir can reduce the metabolism of concomitantly administered protease inhibitors, enhancing their bioavailability and efficacy. MW: 720.94. Purity ≥98% by HPLC |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (3S,4S,6S,9S)-4-hydroxy-12-methyl-9-(1-methylethyl)-13-[2-(1-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis(phenylmethyl)-2,7,10,12-tetraazatridecanoic acid, 5-thiazolylmethyl ester; ABT-538; NSC 693184 |
|---|
| Gene, Accession, CAS # | CAS: 155213-67-5 |
|---|
| Catalog # | B2140-50 |
|---|
| Price | |
|---|
| Order / More Info | Ritonavir from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|